ClinicalTrials.Veeva

Menu

Assessment of Sense of Identity in Patients Diagnosed With Borderline Personality Disorder. A Pilot Study (MASB)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Borderline Personality Disorder

Treatments

Other: Evaluation using the Self-Defining Memory Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT04948905
Local/2021/AS-01
2020-A03352-37 (Registry Identifier)

Details and patient eligibility

About

One of the key features and long considered a fundamental element of Borderline Personality Disorder is the disruption of identity. Autobiographical memory is closely linked to the development and maintenance of a coherent, stable sense of self. It enables the individual to understand who he or she is. The investigators hypothesize that individuals diagnosed with Borderline Personality Disorder have a less coherent, stable sense of the self than healthy controls. The aim of the study is therefore to compare the sense of identity between a group of patients diagnosed with Borderline Personality Disorder and a group of healthy individuals (without Borderline Personality Disorder ).

This can be measured by evaluating the content of the self-defining memory using the Self-Defining Memory scale.

Enrollment

60 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Subject must have given written consent
  • Subject affiliated or beneficiary of a health insurance plan.
  • Adult subjects between 25 and 55 years of age
  • Oral and written mastery of the French language

Inclusion criteria for the borderline group:

  • Subject diagnosed as having borderline personality disorder according to the DSM IV classification

Exclusion criteria for the borderline group:

  • Patients without diagnosis of borderline personality disorder according to the DSM IV classification after taking the SCID II (Structured Clinical Interview for DSM-III-R Axis II Disorders) test

Exclusion criteria for the control group:

  • Subjects considered Borderline after taking the SCID II (Structured Clinical Interview for DSM-III-R Axis II Disorders) test
  • Subjects with a score above 8 on the HADS questionnaire corresponding to questionable symptomatology for anxiety and depressive symptoms.

General exclusion Criteria:

  • Subjects under court protection, guardianship or curatorship
  • Subjects for whom it is impossible to give informed information
  • Subjects participating in a Category 1 or 2 RIPH in the 3 months prior to the study
  • Subject refusing to give written consent
  • Presence of known neurological disease
  • Pregnant or breastfeeding women

Trial design

60 participants in 2 patient groups

Patients diagnosed as having Borderline Personality Disorder
Description:
These patients have been diagnosed as having Borderline Personality Disorder according to the Diagnostic and Statistical Manual IV classification after taking the Structured Clinical Interview for DSM-IV Axis I Disorders test.
Treatment:
Other: Evaluation using the Self-Defining Memory Questionnaire
Healthy Controls (Patients not diagnosed as having Borderline Personality Disorder )
Description:
These patients have NOT been diagnosed as having Borderline Personality Disorder according to the Diagnostic and Statistical Manual IV classification after taking the Structured Clinical Interview for DSM-IV Axis I Disorders test.
Treatment:
Other: Evaluation using the Self-Defining Memory Questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems